UB Paderborn / Katalog / Suche / in CDI

Can we identify patients at risk of life‐threatening allergic reactions to food?

Allergy (Copenhagen), 2016-09, Vol.71 (9), p.1241-1255

2016

Volltextzugriff (PDF)

Non-specific effects of BCG vaccine on viral infections

Clinical microbiology and infection, 2019-12, Vol.25 (12), p.1473-1478

2019

Volltextzugriff (PDF)

Allergen reference doses for precautionary labeling (VITAL 2.0): Clinical implications

Journal of allergy and clinical immunology, 2014-01, Vol.133 (1), p.156-164

2014

Volltextzugriff (PDF)

Establishment of Reference Doses for residues of allergenic foods: Report of the VITAL Expert Panel

Food and chemical toxicology, 2014-01, Vol.63, p.9-17

2014

Volltextzugriff (PDF)

Too clean, or not too clean: the Hygiene Hypothesis and home hygiene

Clinical and experimental allergy, 2006-04, Vol.36 (4), p.402-425

2006

Volltextzugriff (PDF)

Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes

The international journal of tuberculosis and lung disease, 2023-04, Vol.27 (4), p.284

2023

Volltextzugriff (PDF)

How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop

Allergy (Copenhagen), 2018-07, Vol.73 (7), p.1383-1392

2018

Volltextzugriff (PDF)

Approaches to assess IgE mediated allergy risks (sensitization and cross-reactivity) from new or modified dietary proteins

Food and chemical toxicology, 2018-02, Vol.112, p.97-107

2018

Volltextzugriff (PDF)

Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens

Journal of allergy and clinical immunology, 2019-11, Vol.144 (5), p.1290-1309

2019

Volltextzugriff (PDF)

Thresholds for food allergens and their value to different stakeholders

Allergy (Copenhagen), 2008-05, Vol.63 (5), p.597-609

2008

Volltextzugriff (PDF)

The Effect of Type 2 Diabetes Mellitus on the Presentation and Treatment Response of Pulmonary Tuberculosis

Clinical infectious diseases, 2007-08, Vol.45 (4), p.428-435

2007

Volltextzugriff (PDF)

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

Clinical microbiology and infection, 2019-12, Vol.25 (12), p.1468-1472

2019

Volltextzugriff (PDF)

The prevalence, cost and basis of food allergy across Europe

Allergy, 2007-07, Vol.62 (7), p.717-722

2007

Volltextzugriff (PDF)

Improving the diagnosis of tuberculous meningitis: good, but not good enough

Clinical microbiology and infection, 2020-02, Vol.26 (2), p.134-136

2020

Volltextzugriff (PDF)

Heterologous ("Nonspecific") and Sex-Differential Effects of Vaccines: Epidemiology, Clinical Trials, and Emerging Immunologic Mechanisms

Clinical infectious diseases, 2013-07, Vol.57 (2), p.283-289

2013

Volltextzugriff (PDF)

Allergenicity assessment of new or modified protein-containing food sources and ingredients

Food and chemical toxicology, 2024-07, Vol.189, p.114766, Article 114766

2024

Volltextzugriff (PDF)

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

Evidence‐based approaches to the application of precautionary allergen labelling: Report from two iFAAM workshops

Clinical and experimental allergy, 2019-09, Vol.49 (9), p.1191-1200

2019

Volltextzugriff (PDF)

Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

Clinical infectious diseases, 2007-10, Vol.45 (8), p.1001-1007

2007

Volltextzugriff (PDF)

Approaches to risk assessment in food allergy: Report from a workshop ‘‘developing a framework for assessing the risk from allergenic foods

Food and chemical toxicology, 2009-02, Vol.47 (2), p.480-489

2009

Volltextzugriff (PDF)

Threshold dose for peanut: Risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals

Food and chemical toxicology, 2010-03, Vol.48 (3), p.814-819

2010

Volltextzugriff (PDF)

The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus

European journal of clinical microbiology & infectious diseases, 2008-02, Vol.27 (2), p.97-103

2008

Volltextzugriff (PDF)

Probabilistic risk assessment model for allergens in food: sensitivity analysis of the minimum eliciting dose and food consumption

Food and chemical toxicology, 2008-05, Vol.46 (5), p.1437-1443

2008

Volltextzugriff (PDF)

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis

European journal of clinical microbiology & infectious diseases, 2018-02, Vol.37 (2), p.371-380

2018

Volltextzugriff (PDF)

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

Clinical pharmacology and therapeutics, 2015-12, Vol.98 (6), p.622-629

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Can we identify patients at risk of life‐threatening allergic reactions to food?

Non-specific effects of BCG vaccine on viral infections

Allergen reference doses for precautionary labeling (VITAL 2.0): Clinical implications

Establishment of Reference Doses for residues of allergenic foods: Report of the VITAL Expert Panel

Too clean, or not too clean: the Hygiene Hypothesis and home hygiene

Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes

How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop

Approaches to assess IgE mediated allergy risks (sensitization and cross-reactivity) from new or modified dietary proteins

Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens

Thresholds for food allergens and their value to different stakeholders

The Effect of Type 2 Diabetes Mellitus on the Presentation and Treatment Response of Pulmonary Tuberculosis

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

The prevalence, cost and basis of food allergy across Europe

Improving the diagnosis of tuberculous meningitis: good, but not good enough

Heterologous ("Nonspecific") and Sex-Differential Effects of Vaccines: Epidemiology, Clinical Trials, and Emerging Immunologic Mechanisms

Allergenicity assessment of new or modified protein-containing food sources and ingredients

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis

Evidence‐based approaches to the application of precautionary allergen labelling: Report from two iFAAM workshops

Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

Approaches to risk assessment in food allergy: Report from a workshop ‘‘developing a framework for assessing the risk from allergenic foods

Threshold dose for peanut: Risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals

The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus

Probabilistic risk assessment model for allergens in food: sensitivity analysis of the minimum eliciting dose and food consumption

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

Suchergebnisse filtern